Recombinant Human Anti-FAS x Human Anti-CSPG4 Bispecific Antibody (IgG(L)-scFv) (IGLFV-H325)

Recombinant Anti-FAS x Anti-CSPG4 Bispecific Antibody (IgG(L)-scFv) is formed by an IgG and two scFv moieties. The scFv fragments from an anti-FAS antibody are fused to the C terminus of an anti-CSPG4 IgG light (L) chains, or vice versa. It is a type of appended IgGs, which is bispecific and tetravalent (2+2 antigen-binding valency). This BsAb can induce targeted apoptosis. It is designed for the research of Melanoma therapy.

Datasheet INQUIRY

Specifications

Targets

FAS & CSPG4

Type

Appended IgGs

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Melanoma

Targets

Target 1

FAS

Gene ID

355

UniProt ID

P25445

Alternative Names

APT1; CD95; FAS1; APO-1; FASTM; ALPS1A; TNFRSF6; FAS; Fas cell surface death receptor

Target 2

CSPG4

Gene ID

1464

UniProt ID

Q6UVK1

Alternative Names

NG2; Neuron-glial antigen 2; Melanoma-associated chondroitin sulfate proteoglycan; chondroitin sulfate proteoglycan 4; CSPG4; MCSP; MCSPG; MSK16; HMW-MAA; MEL-CSPG

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-FAS x Human Anti-CSPG4 Bispecific Antibody (IgG(L)-scFv) (IGLFV-H325). Click the button below to contact us or submit your feedback about this product.

Recombinant Human Anti-FAS x Human Anti-CSPG4 Bispecific Antibody (IgG(L)-scFv) (CAT#: IGLFV-H325)

Specifications

Targets

Customer Reviews and Q&As